Angi (ANGI) Financials

$16.00 -0.33 (-2.03%)

As of 01:34 PM Eastern

Annual Income Statements for Angi

This table shows Angi's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	36	-41	-128
Consolidated Net Income / (Loss)	37	-40	-128
Net Income / (Loss) Continuing Operations	37	-30	-89
Total Pre-Tax Income	20	-28	-95
Total Operating Income	22	-26	-76
Total Gross Profit	1,128	1,296	1,427
Total Revenue	1,185	1,359	1,764
Operating Revenue	1,185	1,359	1,764
Total Cost of Revenue	58	63	337
Operating Cost of Revenue	58	63	337
Total Operating Expenses	1,106	1,323	1,503
Selling, General & Admin Expense	320	359	447
Marketing Expense	602	765	890
Research & Development Expense	95	97	74
Depreciation Expense	86	94	78
Amortization Expense	2.60	7.96	14
Total Other Income / (Expense), net	-1.81	-1.71	-19
Interest Expense	20	20	20
Other Income / (Expense), net	18	18	1.17
Income Tax Expense	-17	1.84	-5.39
Net Income / (Loss) Discontinued Operations	0.00	-10	-39
Net Income / (Loss) Attributable to Noncontrolling Interest	0.84	0.63	0.47
Basic Earnings per Share	$0.07	($0.08)	($0.26)
Weighted Average Basic Shares Outstanding	498.45M	502.03M	504.78M
Diluted Earnings per Share	$0.07	($0.08)	($0.26)
Weighted Average Diluted Shares Outstanding	498.45M	502.03M	504.78M
Weighted Average Basic & Diluted Shares Outstanding	498.45M	502.03M	504.78M

This table shows Angi's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	15	-1.29	35	3.76	-1.63	-5.56	-5.36	-15	-15	-53	-17
Consolidated Net Income / (Loss)	15	-1.29	35	4.09	-1.32	-5.55	-5.29	-14	-15	-53	-17
Net Income / (Loss) Continuing Operations	15	-1.29	35	4.09	-1.32	2.48	-2.95	-16	-14	-14	-17
Total Pre-Tax Income	20	0.45	8.75	8.72	2.16	8.14	-9.01	-15	-12	-9.14	-18
Total Operating Income	20	2.17	7.82	9.19	2.72	7.63	-7.86	-15	-11	-9.72	-11
Total Gross Profit	233	252	282	301	293	283	338	337	339	313	389
Total Revenue	246	268	297	315	305	300	351	352	355	314	498
Operating Revenue	246	268	297	315	305	300	351	352	355	314	498
Total Cost of Revenue	13	16	15	14	12	17	14	15	17	1.57	109
Operating Cost of Revenue	13	16	15	14	12	17	14	15	17	1.57	109
Total Operating Expenses	213	250	274	292	290	276	345	352	349	323	400
Selling, General & Admin Expense	57	73	77	84	86	71	99	93	97	90	128
Marketing Expense	119	131	155	158	157	157	200	209	200	179	234
Research & Development Expense	27	23	24	25	24	24	21	26	25	19	16
Depreciation Expense	9.95	20	18	24	24	24	22	22	25	32	18
Total Other Income / (Expense), net	-0.22	-1.72	0.93	-0.47	-0.55	0.51	-1.15	0.15	-1.22	0.19	-7.33
Interest Expense	5.04	5.05	5.05	5.04	5.04	5.04	5.04	5.03	5.03	5.03	5.03
Other Income / (Expense), net	4.83	3.33	5.98	4.57	4.48	5.55	3.89	5.18	3.81	-	-2.30
Income Tax Expense	4.68	1.73	-27	4.63	3.48	5.65	-6.06	0.36	1.88	5.30	-0.95
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-	0.20	0.33	0.31	0.02	0.07	0.22	0.33	0.09	0.04
Basic Earnings per Share	$0.30	($0.01)	$0.07	$0.01	$0.00	($0.01)	($0.01)	($0.03)	($0.03)	($0.11)	($0.03)
Weighted Average Basic Shares Outstanding	47.99M	498.45M	497.27M	498.67M	501.74M	502.03M	507.16M	506.28M	506.57M	504.78M	504.47M
Diluted Earnings per Share	$0.30	($0.01)	$0.07	$0.01	$0.00	($0.01)	($0.01)	($0.03)	($0.03)	($0.11)	($0.03)
Weighted Average Diluted Shares Outstanding	47.99M	498.45M	497.27M	498.67M	501.74M	502.03M	507.16M	506.28M	506.57M	504.78M	504.47M
Weighted Average Basic & Diluted Shares Outstanding	47.99M	498.45M	497.27M	498.67M	501.74M	502.03M	507.16M	506.28M	506.57M	504.78M	504.47M

This table details how cash moves in and out of Angi's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	52	53	-127
Net Cash From Operating Activities	156	105	27
Net Cash From Continuing Operating Activities	156	94	46
Net Income / (Loss) Continuing Operations	37	-30	-89
Consolidated Net Income / (Loss)	37	-40	-128
Net Income / (Loss) Discontinued Operations	0.00	-10	-39
Depreciation Expense	86	94	78
Amortization Expense	2.60	7.96	14
Non-Cash Adjustments To Reconcile Net Income	108	134	171
Changes in Operating Assets and Liabilities, net	-77	-111	-127
Net Cash From Discontinued Operating Activities	0.00	11	-19
Net Cash From Investing Activities	-50	-47	-115
Net Cash From Continuing Investing Activities	-50	-47	-115
Purchase of Property, Plant & Equipment	-50	-48	-115
Purchase of Investments	0.00	-12	0.00
Sale of Property, Plant & Equipment	0.08	0.09	0.16
Divestitures	0.00	1.00	0.00
Sale and/or Maturity of Investments	0.00	13	0.00
Net Cash From Financing Activities	-54	-17	-17
Net Cash From Continuing Financing Activities	-54	-17	-17
Repayment of Debt	-0.01	-0.06	-0.26
Repurchase of Common Equity	-29	-11	-8.14
Payment of Dividends	-16	0.00	0.00
Other Financing Activities, net	-9.13	-5.99	-8.83
Effect of Exchange Rate Changes	0.47	0.54	-1.11
Other Net Changes in Cash	0.00	11	-20

This table details how cash moves in and out of Angi's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-30	21	-4.93	37	-0.71	7.77	-3.76	60	-11	-29	-31
Net Cash From Operating Activities	-3.11	40	31	63	22	16	11	57	21	16	4.28
Net Cash From Continuing Operating Activities	-3.11	40	31	63	22	8.94	8.21	56	21	35	4.28
Net Income / (Loss) Continuing Operations	15	-1.29	35	4.09	-1.32	2.48	-2.95	-16	-14	-14	-17
Consolidated Net Income / (Loss)	15	-1.29	35	4.09	-1.32	-5.55	-5.29	-14	-15	-53	-17
Depreciation Expense	9.95	20	18	24	24	24	22	22	25	32	18
Non-Cash Adjustments To Reconcile Net Income	10	22	26	30	30	27	34	38	35	46	41
Changes in Operating Assets and Liabilities, net	-39	-3.23	-48	4.62	-31	-44	-48	9.03	-28	-31	-40
Net Cash From Investing Activities	-12	-13	-12	-13	-13	-11	-14	2.05	-24	-20	-33
Net Cash From Continuing Investing Activities	-12	-13	-12	-13	-13	-11	-14	2.05	-24	-20	-33
Purchase of Property, Plant & Equipment	-13	-13	-12	-13	-13	-12	-14	-10	-12	-20	-33
Sale of Property, Plant & Equipment	0.08	0.08	-	-	0.01	0.07	-	0.00	0.01	-0.06	0.06
Net Cash From Financing Activities	-14	-6.22	-24	-13	-10	-8.75	-0.66	-6.20	-1.38	-3.50	-2.07
Net Cash From Continuing Financing Activities	-14	-6.22	-24	-13	-10	-8.75	-0.66	-6.20	-1.38	-3.50	-2.07
Repurchase of Common Equity	-9.80	-2.93	-7.47	-11	-6.86	-7.54	-	-3.40	0.00	-	-
Other Financing Activities, net	-4.54	-3.28	-0.91	-1.73	-3.21	-1.21	-0.66	-2.75	-1.38	-3.24	-2.07
Effect of Exchange Rate Changes	-0.03	0.03	0.66	-0.07	-0.14	0.41	-0.42	-	-	-	-

This table presents Angi's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	1,831	1,856	1,908
Total Current Assets	495	487	484
Cash & Equivalents	416	364	321
Accounts Receivable	37	51	72
Other Current Assets	42	72	64
Plant, Property, & Equipment, net	80	110	153
Total Noncurrent Assets	1,256	1,259	1,271
Goodwill	883	886	883
Intangible Assets	168	171	178
Noncurrent Deferred & Refundable Income Taxes	169	148	138
Other Noncurrent Operating Assets	36	54	62
Total Liabilities & Shareholders' Equity	1,831	1,856	1,908
Total Liabilities	768	812	856
Total Current Liabilities	232	259	282
Accounts Payable	18	29	30
Accrued Expenses	171	179	183
Current Deferred Revenue	42	50	50
Total Noncurrent Liabilities	536	553	575
Long-Term Debt	497	496	495
Noncurrent Deferred & Payable Income Tax Liabilities	1.50	2.74	2.91
Other Noncurrent Operating Liabilities	38	54	76
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,063	1,045	1,051
Total Preferred & Common Equity	1,063	1,041	1,048
Total Common Equity	1,063	1,041	1,048
Common Stock	1,466	1,448	1,406
Retained Earnings	-195	-231	-190
Treasury Stock	-206	-177	-166
Accumulated Other Comprehensive Income / (Loss)	-2.50	1.19	-1.17
Noncontrolling Interest	0.00	3.74	2.99

This table presents Angi's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,806	1,856	1,852	1,835	1,906	1,902	1,889	1,968
Total Current Assets	465	500	516	482	516	511	486	512
Cash & Equivalents	387	395	385	363	367	371	315	329
Accounts Receivable	40	52	66	61	77	78	92	103
Other Current Assets	38	52	65	58	72	62	67	81
Plant, Property, & Equipment, net	84	86	90	100	121	130	139	167
Total Noncurrent Assets	1,256	1,271	1,247	1,253	1,269	1,261	1,264	1,288
Goodwill	886	888	885	885	883	886	884	903
Intangible Assets	168	171	171	171	170	173	176	180
Noncurrent Deferred & Refundable Income Taxes	170	172	147	147	158	149	144	137
Other Noncurrent Operating Assets	33	40	44	50	56	53	60	69
Total Liabilities & Shareholders' Equity	1,806	1,856	1,852	1,835	1,906	1,902	1,889	1,968
Total Liabilities	756	787	808	792	860	860	841	880
Total Current Liabilities	216	244	261	242	304	303	270	300
Accounts Payable	29	33	21	31	53	37	31	50
Accrued Expenses	152	160	189	162	196	212	189	194
Current Deferred Revenue	35	50	51	50	55	54	50	55
Total Noncurrent Liabilities	540	543	548	550	557	557	570	580
Long-Term Debt	497	497	496	496	496	496	495	495
Noncurrent Deferred & Payable Income Tax Liabilities	1.53	2.05	3.30	3.03	2.92	3.01	2.93	1.66
Other Noncurrent Operating Liabilities	42	44	48	50	58	58	72	83
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,049	1,070	1,044	1,043	1,045	1,042	1,048	1,088
Total Preferred & Common Equity	1,049	1,070	1,040	1,039	1,042	1,038	1,045	1,086
Total Common Equity	1,049	1,070	1,040	1,039	1,042	1,038	1,045	1,086
Common Stock	1,445	1,463	1,464	1,455	1,438	1,427	1,417	1,394
Retained Earnings	-180	-194	-229	-233	-225	-220	-205	-137
Treasury Stock	-217	-203	-195	-184	-170	-170	-166	-166
Accumulated Other Comprehensive Income / (Loss)	0.38	3.28	0.26	0.44	-0.94	1.12	-0.71	-5.21

This table displays calculated financial ratios and metrics derived from Angi's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-12.78%	-22.99%	8.96%
EBITDA Growth	37.87%	454.97%	258.81%
EBIT Growth	598.65%	89.16%	-5.71%
NOPAT Growth	316.55%	64.96%	-11.34%
Net Income Growth	191.41%	68.50%	-81.55%
EPS Growth	187.50%	69.23%	-85.71%
Operating Cash Flow Growth	48.73%	287.33%	335.96%
Free Cash Flow Firm Growth	464.01%	126.54%	51.26%
Invested Capital Growth	-2.83%	-2.61%	-0.32%
Revenue Q/Q Growth	-2.67%	-1.02%	-1.96%
EBITDA Q/Q Growth	-6.31%	36.34%	230.39%
EBIT Q/Q Growth	-16.02%	81.59%	13.65%
NOPAT Q/Q Growth	0.40%	39.56%	12.30%
Net Income Q/Q Growth	13.07%	54.21%	-27.36%
EPS Q/Q Growth	0.00%	55.56%	-30.00%
Operating Cash Flow Q/Q Growth	28.57%	0.32%	425.31%
Free Cash Flow Firm Q/Q Growth	69.29%	-73.84%	60.44%
Invested Capital Q/Q Growth	-2.37%	0.19%	-3.72%
Profitability Metrics	-	-	-
Gross Margin	95.14%	95.40%	80.88%
EBITDA Margin	10.88%	6.88%	0.95%
Operating Margin	1.85%	-1.95%	-4.29%
EBIT Margin	3.40%	-0.59%	-4.22%
Profit (Net Income) Margin	3.11%	-2.97%	-7.25%
Tax Burden Percent	183.53%	142.91%	135.35%
Interest Burden Percent	49.89%	349.50%	127.01%
Effective Tax Rate	-83.53%	0.00%	0.00%
Return on Invested Capital (ROIC)	3.46%	-1.56%	-4.37%
ROIC Less NNEP Spread (ROIC-NNEP)	0.34%	-16.63%	-71.64%
Return on Net Nonoperating Assets (RNNOA)	0.03%	-2.29%	-7.28%
Return on Equity (ROE)	3.50%	-3.85%	-11.65%
Cash Return on Invested Capital (CROIC)	6.33%	1.09%	-4.06%
Operating Return on Assets (OROA)	2.18%	-0.43%	-3.80%
Return on Assets (ROA)	2.00%	-2.14%	-6.53%
Return on Common Equity (ROCE)	3.49%	-3.83%	-11.58%
Return on Equity Simple (ROE_SIMPLE)	3.47%	-3.87%	-12.21%
Net Operating Profit after Tax (NOPAT)	40	-19	-53
NOPAT Margin	3.39%	-1.37%	-3.00%
Net Nonoperating Expense Percent (NNEP)	3.12%	15.08%	67.27%
Return On Investment Capital (ROIC_SIMPLE)	2.58%	-1.20%	-3.42%
Cost of Revenue to Revenue	4.86%	4.60%	19.12%
SG&A Expenses to Revenue	27.00%	26.45%	25.34%
R&D to Revenue	8.05%	7.11%	4.18%
Operating Expenses to Revenue	93.29%	97.35%	85.16%
Earnings before Interest and Taxes (EBIT)	40	-8.07	-74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	129	93	17
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.78	1.21	1.13
Price to Tangible Book Value (P/TBV)	70.56	0.00	0.00
Price to Revenue (P/Rev)	0.70	0.93	0.67
Price to Earnings (P/E)	22.93	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	4.36%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.79	1.19	1.13
Enterprise Value to Revenue (EV/Rev)	0.76	1.03	0.77
Enterprise Value to EBITDA (EV/EBITDA)	7.03	14.96	80.89
Enterprise Value to EBIT (EV/EBIT)	22.51	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	22.55	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	5.81	13.34	50.34
Enterprise Value to Free Cash Flow (EV/FCFF)	12.33	107.36	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.47	0.47	0.47
Long-Term Debt to Equity	0.47	0.47	0.47
Financial Leverage	0.10	0.14	0.10
Leverage Ratio	1.75	1.80	1.78
Compound Leverage Factor	0.87	6.28	2.27
Debt to Total Capital	31.86%	32.20%	32.02%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	31.86%	32.20%	32.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.24%	0.19%
Common Equity to Total Capital	68.14%	67.56%	67.78%
Debt to EBITDA	3.85	5.31	29.40
Net Debt to EBITDA	0.62	1.41	10.34
Long-Term Debt to EBITDA	3.85	5.31	29.40
Debt to NOPAT	12.37	-26.74	-9.36
Net Debt to NOPAT	2.00	-7.12	-3.29
Long-Term Debt to NOPAT	12.37	-26.74	-9.36
Altman Z-Score	1.39	1.62	1.61
Noncontrolling Interest Sharing Ratio	0.18%	0.32%	0.63%
Liquidity Ratios	-	-	-
Current Ratio	2.14	1.88	1.72
Quick Ratio	1.96	1.61	1.40
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	73	13	-49
Operating Cash Flow to CapEx	309.34%	219.82%	23.47%
Free Cash Flow to Firm to Interest Expense	3.64	0.65	-2.44
Operating Cash Flow to Interest Expense	7.73	5.21	1.35
Operating Cash Flow Less CapEx to Interest Expense	5.23	2.84	-4.39
Efficiency Ratios	-	-	-
Asset Turnover	0.64	0.72	0.90
Accounts Receivable Turnover	27.00	22.08	22.29
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	12.53	10.37	13.03
Accounts Payable Turnover	2.41	2.09	9.74
Days Sales Outstanding (DSO)	13.52	16.53	16.37
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	151.46	174.66	37.46
Cash Conversion Cycle (CCC)	-137.95	-158.13	-21.09
Capital & Investment Metrics	-	-	-
Invested Capital	1,143	1,177	1,208
Invested Capital Turnover	1.02	1.14	1.46
Increase / (Decrease) in Invested Capital	-33	-32	-3.86
Enterprise Value (EV)	906	1,399	1,363
Market Capitalization	825	1,263	1,186
Book Value per Share	$2.14	$2.05	$2.08
Tangible Book Value per Share	$0.02	($0.03)	($0.03)
Total Capital	1,560	1,541	1,547
Total Debt	497	496	495
Total Long-Term Debt	497	496	495
Net Debt	80	132	174
Capital Expenditures (CapEx)	50	48	115
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-153	-135	-119
Debt-free Net Working Capital (DFNWC)	263	229	202
Net Working Capital (NWC)	263	229	202
Net Nonoperating Expense (NNE)	3.32	22	75
Net Nonoperating Obligations (NNO)	80	132	157
Total Depreciation and Amortization (D&A)	89	102	91
Debt-free, Cash-free Net Working Capital to Revenue	-12.91%	-9.97%	-6.73%
Debt-free Net Working Capital to Revenue	22.23%	16.82%	11.47%
Net Working Capital to Revenue	22.23%	16.82%	11.47%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.07	($0.08)	($0.26)
Adjusted Weighted Average Basic Shares Outstanding	498.45M	502.03M	504.78M
Adjusted Diluted Earnings per Share	$0.07	($0.08)	($0.26)
Adjusted Weighted Average Diluted Shares Outstanding	498.45M	502.03M	504.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	498.45M	502.03M	504.78M
Normalized Net Operating Profit after Tax (NOPAT)	15	-19	-53
Normalized NOPAT Margin	1.29%	-1.37%	-3.00%
Pre Tax Income Margin	1.69%	-2.08%	-5.36%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	2.00	-0.40	-3.70
NOPAT to Interest Expense	1.99	-0.92	-2.63
EBIT Less CapEx to Interest Expense	-0.50	-2.77	-9.44
NOPAT Less CapEx to Interest Expense	-0.51	-3.29	-8.37
Payout Ratios	-	-	-
Dividend Payout Ratio	43.47%	0.00%	0.00%
Augmented Payout Ratio	121.10%	-27.12%	-6.36%

This table displays calculated financial ratios and metrics derived from Angi's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-19.48%	-10.84%	-15.52%	-10.37%	-14.09%	-4.44%	-29.48%	-31.83%	-18.49%	-10.11%	7.90%
EBITDA Growth	12.01%	-23.42%	48.27%	163.17%	49.43%	48.04%	157.66%	364.15%	228.62%	700.50%	164.58%
EBIT Growth	244.88%	-58.30%	447.33%	234.91%	201.78%	235.53%	70.26%	54.95%	79.17%	53.61%	13.58%
NOPAT Growth	1,023.01%	-367.00%	673.98%	140.02%	78.28%	134.21%	28.90%	26.36%	67.96%	52.18%	26.15%
Net Income Growth	1,247.00%	76.81%	768.87%	128.23%	91.22%	89.59%	69.68%	39.66%	54.94%	-106.73%	-4.47%
EPS Growth	1,100.00%	0.00%	800.00%	133.33%	100.00%	90.91%	66.67%	40.00%	57.14%	-120.00%	0.00%
Operating Cash Flow Growth	-113.96%	149.50%	180.57%	10.75%	5.31%	2.14%	157.51%	624.43%	2,980.54%	179.84%	112.82%
Free Cash Flow Firm Growth	-18.19%	-20.10%	-53.34%	-72.21%	736.21%	1,250.69%	204.94%	145.04%	91.79%	95.63%	-5.22%
Invested Capital Growth	-1.40%	-2.83%	-0.29%	-0.97%	-3.32%	-2.61%	-6.41%	-5.42%	-0.13%	-0.32%	5.35%
Revenue Q/Q Growth	-8.20%	-9.72%	-5.84%	3.19%	9.14%	-14.46%	-0.10%	-1.10%	13.08%	-36.88%	-3.44%
EBITDA Q/Q Growth	22.44%	-9.44%	-17.64%	22.65%	-20.00%	75.33%	46.19%	-30.36%	-17.06%	205.15%	249.87%
EBIT Q/Q Growth	352.05%	-60.18%	0.28%	91.07%	-53.30%	431.62%	61.05%	-44.15%	27.21%	27.22%	41.01%
NOPAT Q/Q Growth	345.72%	-119.67%	633.10%	360.44%	-136.11%	142.29%	48.89%	-41.36%	-11.96%	12.11%	47.06%
Net Income Q/Q Growth	1,274.65%	-103.64%	765.04%	410.40%	76.25%	-4.88%	63.49%	3.47%	71.84%	-205.40%	27.33%
EPS Q/Q Growth	3,100.00%	-114.29%	600.00%	0.00%	100.00%	0.00%	66.67%	0.00%	72.73%	-266.67%	40.00%
Operating Cash Flow Q/Q Growth	-107.78%	29.50%	-50.69%	181.18%	313.96%	45.63%	-80.53%	167.37%	34.76%	267.17%	-45.24%
Free Cash Flow Firm Q/Q Growth	17.02%	-22.56%	124.35%	-59.76%	7.17%	-54.78%	33.64%	1,021.13%	-106.72%	95.88%	42.64%
Invested Capital Q/Q Growth	1.43%	-2.37%	1.32%	-1.72%	-0.05%	0.19%	0.63%	-4.06%	0.68%	-3.72%	1.70%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	94.71%	93.96%	95.03%	95.51%	95.91%	94.26%	96.11%	95.82%	95.24%	99.50%	78.10%
EBITDA Margin	14.14%	10.60%	10.57%	12.08%	10.17%	12.35%	6.02%	4.12%	5.84%	7.97%	1.65%
Operating Margin	8.13%	0.81%	2.63%	2.92%	0.89%	2.54%	-2.24%	-4.37%	-3.06%	-3.09%	-2.22%
EBIT Margin	10.10%	2.05%	4.65%	4.37%	2.36%	4.38%	-1.13%	-2.90%	-1.99%	-3.09%	-2.68%
Profit (Net Income) Margin	6.14%	-0.48%	11.92%	1.30%	-0.43%	-1.85%	-1.51%	-4.12%	-4.22%	-16.94%	-3.50%
Tax Burden Percent	76.34%	-287.05%	404.10%	46.90%	-60.92%	-68.16%	58.69%	95.06%	123.94%	582.57%	94.86%
Interest Burden Percent	79.69%	8.16%	63.43%	63.36%	30.03%	61.76%	226.81%	149.37%	171.09%	94.06%	137.67%
Effective Tax Rate	23.66%	387.05%	-304.10%	53.10%	160.92%	69.48%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	5.99%	-2.37%	11.06%	1.50%	-0.59%	0.88%	-1.77%	-3.88%	-2.96%	-3.16%	-2.29%
ROIC Less NNEP Spread (ROIC-NNEP)	5.85%	2.27%	14.33%	1.31%	-0.37%	-4.57%	-1.62%	-6.74%	-8.40%	-44.80%	-12.83%
Return on Net Nonoperating Assets (RNNOA)	0.68%	0.23%	1.56%	0.15%	-0.05%	-0.63%	-0.22%	-0.82%	-1.05%	-4.55%	-1.04%
Return on Equity (ROE)	6.67%	-2.14%	12.62%	1.65%	-0.65%	0.25%	-2.00%	-4.69%	-4.02%	-7.71%	-3.33%
Cash Return on Invested Capital (CROIC)	6.15%	6.33%	3.70%	1.20%	2.62%	1.09%	4.10%	2.83%	-2.90%	-4.06%	-10.14%
Operating Return on Assets (OROA)	6.24%	1.32%	3.01%	2.96%	1.66%	3.17%	-0.80%	-2.25%	-1.72%	-2.78%	-2.39%
Return on Assets (ROA)	3.80%	-0.31%	7.72%	0.88%	-0.30%	-1.33%	-1.07%	-3.19%	-3.65%	-15.25%	-3.12%
Return on Common Equity (ROCE)	6.65%	-2.14%	12.60%	1.64%	-0.64%	0.25%	-1.99%	-4.66%	-3.99%	-7.66%	-3.30%
Return on Equity Simple (ROE_SIMPLE)	5.08%	0.00%	3.05%	-0.78%	-2.56%	0.00%	-8.45%	-9.65%	-10.50%	0.00%	-9.26%
Net Operating Profit after Tax (NOPAT)	15	-6.21	32	4.31	-1.65	2.33	-5.50	-11	-7.62	-6.80	-7.74
NOPAT Margin	6.21%	-2.32%	10.65%	1.37%	-0.54%	0.77%	-1.57%	-3.06%	-2.14%	-2.16%	-1.55%
Net Nonoperating Expense Percent (NNEP)	0.14%	-4.64%	-3.28%	0.19%	-0.22%	5.45%	-0.15%	2.87%	5.44%	41.64%	10.54%
Return On Investment Capital (ROIC_SIMPLE)	0.99%	-0.40%	-	-	-	0.15%	-	-	-	-0.44%	-
Cost of Revenue to Revenue	5.29%	6.04%	4.97%	4.49%	4.09%	5.74%	3.89%	4.18%	4.76%	0.50%	21.90%
SG&A Expenses to Revenue	23.31%	27.36%	25.89%	26.77%	28.00%	23.58%	28.10%	26.50%	27.19%	28.50%	25.75%
R&D to Revenue	11.01%	8.40%	8.19%	7.86%	7.78%	8.05%	6.12%	7.27%	7.12%	6.10%	3.18%
Operating Expenses to Revenue	86.57%	93.15%	92.39%	92.59%	95.02%	91.72%	98.35%	100.19%	98.30%	102.59%	80.32%
Earnings before Interest and Taxes (EBIT)	25	5.49	14	14	7.20	13	-3.97	-10	-7.07	-9.72	-13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	35	28	31	38	31	37	21	14	21	25	8.21
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.73	0.78	1.20	0.93	1.27	1.21	0.96	1.61	1.10	1.13	1.37
Price to Tangible Book Value (P/TBV)	0.00	70.56	125.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	596.75
Price to Revenue (P/Rev)	0.68	0.70	1.06	0.76	1.01	0.93	0.73	1.10	0.68	0.67	0.83
Price to Earnings (P/E)	14.56	22.93	40.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.87%	4.36%	2.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.76	0.79	1.19	0.93	1.24	1.19	0.97	1.54	1.08	1.13	1.32
Enterprise Value to Revenue (EV/Rev)	0.78	0.76	1.14	0.85	1.11	1.03	0.83	1.18	0.78	0.77	0.92
Enterprise Value to EBITDA (EV/EBITDA)	6.76	7.03	10.09	8.47	14.00	14.96	16.55	29.13	26.99	80.89	0.00
Enterprise Value to EBIT (EV/EBIT)	15.18	22.51	28.96	35.79	234.12	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	15.87	22.55	34.69	401.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	6.73	5.81	11.44	10.64	15.24	13.34	10.86	18.41	26.90	50.34	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	12.24	12.33	31.98	77.26	46.29	107.36	22.80	53.04	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.47	0.47	0.46	0.48	0.48	0.47	0.47	0.48	0.47	0.47	0.45
Long-Term Debt to Equity	0.47	0.47	0.46	0.48	0.48	0.47	0.47	0.48	0.47	0.47	0.45
Financial Leverage	0.12	0.10	0.11	0.11	0.14	0.14	0.14	0.12	0.13	0.10	0.08
Leverage Ratio	1.74	1.75	1.78	1.80	1.78	1.80	1.82	1.83	1.80	1.78	1.79
Compound Leverage Factor	1.39	0.14	1.13	1.14	0.53	1.11	4.12	2.73	3.08	1.68	2.46
Debt to Total Capital	32.15%	31.86%	31.71%	32.22%	32.24%	32.20%	32.17%	32.24%	32.09%	32.02%	31.26%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	32.15%	31.86%	31.71%	32.22%	32.24%	32.20%	32.17%	32.24%	32.09%	32.02%	31.26%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.28%	0.26%	0.24%	0.23%	0.24%	0.22%	0.19%	0.18%
Common Equity to Total Capital	67.85%	68.14%	68.29%	67.49%	67.50%	67.56%	67.59%	67.53%	67.69%	67.78%	68.55%
Debt to EBITDA	3.82	3.85	3.61	3.90	4.78	5.31	7.23	8.02	10.15	29.40	-38.32
Net Debt to EBITDA	0.85	0.62	0.74	0.88	1.28	1.41	1.88	2.02	3.44	10.34	-12.87
Long-Term Debt to EBITDA	3.82	3.85	3.61	3.90	4.78	5.31	7.23	8.02	10.15	29.40	-38.32
Debt to NOPAT	8.98	12.37	12.41	184.92	-54.95	-26.74	-16.16	-15.05	-13.47	-9.36	-8.20
Net Debt to NOPAT	2.00	2.00	2.53	41.55	-14.72	-7.12	-4.20	-3.80	-4.57	-3.29	-2.76
Long-Term Debt to NOPAT	8.98	12.37	12.41	184.92	-54.95	-26.74	-16.16	-15.05	-13.47	-9.36	-8.20
Altman Z-Score	1.30	1.33	1.68	1.42	1.70	1.66	1.38	1.92	1.68	1.73	1.94
Noncontrolling Interest Sharing Ratio	0.19%	0.18%	0.17%	0.38%	0.35%	0.32%	0.30%	0.68%	0.67%	0.63%	0.81%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.15	2.14	2.05	1.98	1.99	1.88	1.70	1.69	1.80	1.72	1.71
Quick Ratio	1.98	1.96	1.84	1.73	1.75	1.61	1.46	1.48	1.55	1.40	1.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	32	27	35	16	39	34	75	56	-6.09	-2.95	-71
Operating Cash Flow to CapEx	-24.91%	311.09%	255.44%	495.75%	174.30%	138.32%	79.91%	541.59%	178.64%	78.48%	12.84%
Free Cash Flow to Firm to Interest Expense	6.28	5.37	6.93	3.09	7.69	6.73	14.89	11.14	-1.21	-0.59	-14.20
Operating Cash Flow to Interest Expense	-0.62	7.94	6.13	12.44	4.43	3.19	2.19	11.24	4.21	3.12	0.85
Operating Cash Flow Less CapEx to Interest Expense	-3.10	5.38	3.73	9.93	1.89	0.88	-0.55	9.17	1.85	-0.86	-5.77
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.62	0.64	0.65	0.68	0.70	0.72	0.71	0.78	0.86	0.90	0.89
Accounts Receivable Turnover	22.23	27.00	18.78	17.57	17.09	22.08	15.23	15.33	17.51	22.29	17.86
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	12.25	12.53	11.77	11.60	10.95	10.37	9.51	10.63	12.15	13.03	12.67
Accounts Payable Turnover	1.96	2.41	1.36	1.99	1.89	2.09	0.91	3.62	5.83	9.74	8.63
Days Sales Outstanding (DSO)	16.42	13.52	19.43	20.77	21.35	16.53	23.96	23.81	20.85	16.37	20.43
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	186.02	151.46	267.46	183.51	193.32	174.66	401.55	100.86	62.59	37.46	42.32
Cash Conversion Cycle (CCC)	-169.60	-137.95	-248.03	-162.73	-171.96	-158.13	-377.59	-77.05	-41.75	-21.09	-21.88
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,160	1,143	1,171	1,156	1,176	1,177	1,174	1,167	1,216	1,208	1,255
Invested Capital Turnover	0.96	1.02	1.04	1.10	1.09	1.14	1.13	1.27	1.38	1.46	1.47
Increase / (Decrease) in Invested Capital	-16	-33	-3.39	-11	-40	-32	-80	-67	-1.53	-3.86	64
Enterprise Value (EV)	879	906	1,388	1,079	1,452	1,399	1,135	1,800	1,317	1,363	1,654
Market Capitalization	768	825	1,287	963	1,315	1,263	1,002	1,672	1,146	1,186	1,485
Book Value per Share	$2.10	$2.14	$2.14	$2.07	$2.07	$2.05	$2.06	$2.05	$2.07	$2.08	$2.16
Tangible Book Value per Share	($0.01)	$0.02	$0.02	($0.03)	($0.03)	($0.03)	($0.02)	($0.04)	($0.03)	($0.03)	$0.00
Total Capital	1,546	1,560	1,566	1,541	1,539	1,541	1,541	1,538	1,544	1,547	1,584
Total Debt	497	497	497	496	496	496	496	496	495	495	495
Total Long-Term Debt	497	497	497	496	496	496	496	496	495	495	495
Net Debt	110	80	101	112	133	132	129	125	168	174	166
Capital Expenditures (CapEx)	12	13	12	13	13	12	14	10	12	20	33
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-137	-153	-139	-130	-124	-135	-155	-163	-111	-119	-116
Debt-free Net Working Capital (DFNWC)	249	263	256	255	240	229	212	208	216	202	212
Net Working Capital (NWC)	249	263	256	255	240	229	212	208	216	202	212
Net Nonoperating Expense (NNE)	0.16	-4.93	-3.77	0.22	-0.34	7.87	-0.22	3.71	7.38	46	9.70
Net Nonoperating Obligations (NNO)	110	80	101	112	133	132	129	125	168	157	166
Total Depreciation and Amortization (D&A)	9.95	23	18	24	24	24	25	25	28	35	22
Debt-free, Cash-free Net Working Capital to Revenue	-12.21%	-12.91%	-11.44%	-10.19%	-9.46%	-9.97%	-11.27%	-10.70%	-6.61%	-6.73%	-6.47%
Debt-free Net Working Capital to Revenue	22.14%	22.23%	21.02%	20.06%	18.31%	16.82%	15.45%	13.68%	12.84%	11.47%	11.80%
Net Working Capital to Revenue	22.14%	22.23%	21.02%	20.06%	18.31%	16.82%	15.45%	13.68%	12.84%	11.47%	11.80%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.30	($0.01)	$0.07	$0.01	$0.00	($0.01)	($0.01)	($0.03)	($0.03)	($0.11)	($0.03)
Adjusted Weighted Average Basic Shares Outstanding	47.99M	498.45M	497.27M	498.67M	501.74M	502.03M	507.16M	506.28M	506.57M	504.78M	504.47M
Adjusted Diluted Earnings per Share	$0.30	($0.01)	$0.07	$0.01	$0.00	($0.01)	($0.01)	($0.03)	($0.03)	($0.11)	($0.03)
Adjusted Weighted Average Diluted Shares Outstanding	47.99M	498.45M	497.27M	498.67M	501.74M	502.03M	507.16M	506.28M	506.57M	504.78M	504.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	47.99M	498.45M	497.27M	498.67M	501.74M	502.03M	507.16M	506.28M	506.57M	504.78M	504.47M
Normalized Net Operating Profit after Tax (NOPAT)	15	1.52	5.47	6.43	1.90	5.34	-5.50	-11	-7.62	-6.80	-7.74
Normalized NOPAT Margin	6.21%	0.57%	1.84%	2.04%	0.62%	1.78%	-1.57%	-3.06%	-2.14%	-2.16%	-1.55%
Pre Tax Income Margin	8.05%	0.17%	2.95%	2.77%	0.71%	2.71%	-2.57%	-4.33%	-3.40%	-2.91%	-3.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.92	1.09	2.73	2.73	1.43	2.62	-0.79	-2.03	-1.41	-1.93	-2.65
NOPAT to Interest Expense	3.03	-1.23	6.26	0.85	-0.33	0.46	-1.09	-2.14	-1.51	-1.35	-1.54
EBIT Less CapEx to Interest Expense	2.44	-1.46	0.34	0.22	-1.11	0.31	-3.53	-4.10	-3.76	-5.91	-9.28
NOPAT Less CapEx to Interest Expense	0.55	-3.78	3.86	-1.65	-2.87	-1.84	-3.83	-4.22	-3.87	-5.33	-8.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	43.47%	49.15%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	59.22%	121.10%	151.06%	-319.27%	-66.82%	-27.12%	-3.86%	-3.39%	0.00%	-6.36%	-8.10%

Frequently Asked Questions About Angi's Financials

When does Angi's financial year end?

According to the most recent income statement we have on file, Angi's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Angi's net income changed over the last 2 years?

Angi's net income appears to be on a downward trend, with a most recent value of $36.85 million in 2024, falling from -$127.98 million in 2022. The previous period was -$40.31 million in 2023. See where experts think Angi is headed by visiting Angi's forecast page.

What is Angi's operating income?

Angi's total operating income in 2024 was $21.89 million, based on the following breakdown:

Total Gross Profit: $1.13 billion
Total Operating Expenses: $1.11 billion

How has Angi revenue changed over the last 2 years?

Over the last 2 years, Angi's total revenue changed from $1.76 billion in 2022 to $1.19 billion in 2024, a change of -32.8%.

How much debt does Angi have?

Angi's total liabilities were at $767.93 million at the end of 2024, a 5.4% decrease from 2023, and a 10.3% decrease since 2022.

How much cash does Angi have?

In the past 2 years, Angi's cash and equivalents has ranged from $321.16 million in 2022 to $416.43 million in 2024, and is currently $416.43 million as of their latest financial filing in 2024.

How has Angi's book value per share changed over the last 2 years?

Over the last 2 years, Angi's book value per share changed from 2.08 in 2022 to 2.14 in 2024, a change of 2.8%.

Related Companies

This page (NASDAQ:ANGI) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Angi (ANGI) Financials

Frequently Asked Questions About Angi's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Angi (ANGI) Financials

Annual Income Statements for Angi

Quarterly Income Statements for Angi

Annual Cash Flow Statements for Angi

Quarterly Cash Flow Statements for Angi

Annual Balance Sheets for Angi

Quarterly Balance Sheets for Angi

Annual Metrics And Ratios for Angi

Quarterly Metrics And Ratios for Angi

Frequently Asked Questions About Angi's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools